Abstract
To the Editor. — Mustacchi and Greenspan observed what appeared to be a high correlation between older ages at breast diagnosis and long duration of thyroid supplement administration. On reanalysis of their data using odds ratio analyses, I came up with a somewhat different interpretation of their findings. If one were to take the observed cases of breast and compare them with the no cancer group and analyze them for history and duration of thyroid supplements (all age groups), one finds the following: By this analysis, risk for breast appears to be greater with use and duration of use of thyroid supplements. However, this analysis tells us nothing about age. If, however, one were to split the study and comparison patients into younger and older groups (55 years and younger and over 55 years at diagnosis) one finds the following: One sees by this analysis that the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
